New Protein Fund

  • DATABASE (963)

  • ARTICLES (736)

    • DATABASE (963)
    • ARTICLES (736)
  • Sort by
    • Relevance
    • Date

The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.

Jose Francis Cianni is the Italian-born co-founder and CEO and CFO for Italy of Italo-Spanish insect protein manufacturer Nutrinsect, where he has worked since 2016. Cianni is also in charge of HR and admin and previously worked as a sports technical director.   

Founded in 2017 in Hong Kong, Happiness Capital invests in seed to growth stage companies in the US, Europe, Israel, and China, with a focus on issues affecting global happiness within the areas of citizen trust, food, health, climate change, and reduced inequalities. It hosts its own annual contest, the Super Happiness Challenge , a global open innovation contest to fund individuals and startups with ideas and new products or services that tapped into unmet needs to achieve happiness, with a possible $1m in total investment on offer. The VC currently has 37 startups in its portfolio, around half of which are in foodtech and agtech. Its most recent investments include leading the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions, and co-leading the $29m February 2021 Series A round of Israeli 3D printed alt-meat startup Redefine Meat.

New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio.  Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech. 

After graduating with an Industrial Engineering degree from Purdue University in the US, Sean DeWitt became a management consultant at PricewaterhouseCoopers. He later worked at the US Department of State and the Fund for New York City.In 2007, he joined the nonprofit Grameen Foundation that was established by Grameen Bank founder Muhammad Yunus. As part of the nonprofit, he helped Aldi Haryopratomo establish the social enterprise Ruma.  DeWitt currently works for the World Resource Institute. He also holds master’s degrees in Development Finance and Environmental Economics from the University of London.

NEA was founded in 1978 and is one of the largest venture capital firms in the world today. They have more than US$17 billion in committed capital across 15 funds. NEA has invested US$400 million in over 20 companies in China to date, including Uroaming, GrowingIO, Gushengtang, 51lietou and Baihe.

With the State Council’s approval, the China State-Owned VC Fund was established and financed by China Construction Bank Corporation, China Reform Holdings Corporation, Ltd. (CRHC), the Postal Savings Bank of China and Shenzhen Investment Holding Co., Ltd. in 2016. The fund had initial capital of RMB 100 billion, 34 billion of which came from state-owned CRHC, which is also the fund’s main sponsor and controlling shareholder. The China State-Owned VC Fund is committed to helping centrally-administered state companies develop by investing in technological upgrades in the fields of robotics, AI, big data, mobile finance, electric vehicles, new energy, etc.

Jose Vidal Obón is the Spanish-born co-founder, CEO and CFO for Spain of Italo-Spanish insect protein manufacturer Nutrinsect, where he has worked since 2016. He is also on the Spanish board of insurance company AXA. Prior to Nutrinsect, he worked for six years as manager of Madrid-based insurance company Crédito y Caución and for two years as supervisor at Italian bank Banca Mediolanum. Vidal is an economics graduate.   

San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods. 

Nour Akbaraly completed a master’s in engineering at Centrale Lille and also a master’s in applied mathematics at Lille University in 2010. In 2011, Akbaraly joined industrial manufacturing consultancy firm Avencore as a consultant in Paris.The avid photographer and F&B enthusiast also went to various tea-tasting classes at a tea specialist college until 2015. Passionate about gastronomy, he began exploring alt-protein alternatives to address the environmental and ethical challenges of food supply chains.In 2016, he went on an engineering training course for agronomy and agri-food at AgroSup Dijon, the National Institute of Agronomic, Food and Environmental Sciences.A year later, he founded Les Noveaux Affineurs, a startup specializing in plant-based alternatives to cheese. His ambition is to create a new range of French gastronomic vegan cheese products for consumers in France and overseas.Since 2010, Akbaraly is also a volunteer at the Action Contre la Faim, a Paris-based international NGO founded in 1979. The “Action Against Hunger” projects include running awareness campaigns on food security issues in colleges and schools in France and other countries like India and Sudan.

Fondazione Marche, founded in 2009, is a private, non-profit business promotion organization that operates exclusively in the Italian territory of the Marche Region in central-eastern Italy. It is based in the regional capital Ancona. The organization was established by local business leaders in association with banks Banca Popolare di Ancona and BPU, who funded the company with €15m.  It invests across sectors and technologies, with both tech and non-tech startups supported. Its most recent investment to date was in Italo-Spanish insect protein flour manufacturer Nutrinsect, with a €350,000 pre-seed investment in May 2020. 

Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO.  Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications,  developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley 

With the aim of supporting Hong Kong to develop into a world-class tech innovation center and cooperating with Guangdong and Macau enterprises to support the development of the Guangdong-Hong Kong-Macao Greater Bay Area, large-sized mainland enterprises operating in Hong Kong, Hong Kong companies, mainland private firms and new economy enterprises initiated Greater Bay Area Homeland Development Fund in 2018. With a total capital volume of over HK$100bn, it is managed by Greater Bay Area Homeland Investments. The fund will also provide help to enterprises in the Greater Bay Area to export products to overseas markets.

Ramkumar Nair graduated in biotechnology at the Cochin University of Science and Technology in Kerala before going to Sweden for postgrad studies in 2013.During his PhD in industrial biotechnology at the University of Borås, he embarked on a research project to create fungi-based proteins from discarded sidestreams generated by food producers. After extensive research in 2017, he founded Mycorena in Gothenburg to produce mycoproteins using fermentation technology.The startup’s first commercial product, Promyc, is now being sold to global food companies as a more sustainable and nutritional alt-protein compared to traditional plant-based proteins.

Founded in 2007, the Shenzhen-based CDF Capital runs a RMB 4.2 billion PE fund for investments in new materials, new IT, consumer, cleantech and healthcare tech sectors. It has backed over 120 companies to date.

Sorry, we couldn’t find any matches for “New Protein Fund”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.